Article metrics

Download PDFPDF

Original article
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

 

Online download statistics by month:

Online download statistics by month: March 2016 to April 2021

AbstractFullPdf
Mar 20161018614511
Apr 20161783543940
May 20161256421480
Jun 2016497211250
Jul 2016275114148
Aug 2016252153150
Sep 2016213154288
Oct 2016258167244
Nov 2016286173192
Dec 2016130126187
Jan 2017130110114
Feb 20173264102
Mar 20173124121
Apr 20175207108
May 2017118265
Jun 20176819991
Jul 201717416079
Aug 201721417273
Sep 201718016161
Oct 2017215179123
Nov 201717914767
Dec 20171219756
Jan 201814010779
Feb 201817212665
Mar 201827121748
Apr 20181099140
May 20181017737
Jun 201812110331
Jul 201813012635
Aug 201815718027
Sep 20188011021
Oct 201812014837
Nov 201811113422
Dec 201813014920
Jan 20199112030
Feb 201910113429
Mar 20197612242
Apr 20198711535
May 20191029624
Jun 2019817326
Jul 20191046533
Aug 2019332921
Sep 2019594731
Oct 2019946731
Nov 2019837025
Dec 2019775113
Jan 2020937131
Feb 2020444219
Mar 2020786826
Apr 2020676432
May 2020686331
Jun 2020645122
Jul 2020514417
Aug 2020524120
Sep 2020655418
Oct 20201097123
Nov 2020565219
Dec 2020654828
Jan 2021575215
Feb 2021635026
Mar 2021585419
Apr 2021565226
Total1096679125624